ArticleEMBO molecular medicine2017

Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.

Daniela Tosoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.